Video: Superheroes, Secret Identities & You| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: Social media

Get Excited for ACR Convergence 2024

From the College  |  September 9, 2024

An engaging mix of new and returning programming is planned for ACR Convergence in Washington, D.C. “ACR Convergence is unique because of the blend of high-quality science, updates on advances in clinical care and networking opportunities to advance the field of rheumatology,” says Annual Meeting Planning Committee (AMPC) Chair Gregory C. Gardner, MD, MACP. “We…

Filed under:ACR ConvergenceMeeting Reports Tagged with:ACR Convergence 2024

CAR-T Cells: Are We Closer to Drug-Free Remission Than We Think?

Samantha C. Shapiro, MD  |  July 8, 2024

Most Sunday mornings, I make myself an exceptional cup of pour-over coffee and sit down on my deck with the latest issue of the New England Journal of Medicine. I check out the image of the week. I read the case report with pen in hand, racing to diagnose the patient before the authors spill…

Filed under:Drug UpdatesGuidanceResearch Rheum Tagged with:CAR-T cell therapyRemission

Advice for New Rheumatology Fellows: Construct Winner’s Triangles

Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS  |  June 10, 2024

June is always a bittersweet month, at least in academic medicine. We get to look forward to a new fresh set of faces coming into our training programs, but we also have to say goodbye to those once-fresh faces that have progressed through their medical education journeys. These transitions are never easy, neither for the…

Filed under:CareerCareer DevelopmentOpinionRheuminations Tagged with:coachFellowsFellows-in-TrainingMentoring

FTC Bans Noncompete Agreements: What Rheumatologists Need to Know

From the College  |  May 5, 2024

The ACR applauds the FTC’s recent ban on most noncompete agreements. The ruling is a step in the right direction toward a more competitive market for healthcare workers and their services.

Filed under:Legislation & AdvocacyWorkforce Tagged with:ACR advocacynoncompete agreements

The Biases We Don’t Know We Hold

Vanessa Caceres  |  March 26, 2024

Implicit bias can affect patient care at the physician level when they’re making treatment decisions and at the healthcare organization level when they’re choosing new hires. Here are insights into strategies rheumatologists can use to become aware of, and question, their implicit biases.

Filed under:OpinionPractice SupportWorkforce Tagged with:biasdiscriminationEquityinclusion

Striving for Equity

Glen Rodman  |  December 5, 2023

SAN DIEGO—At ACR Convergence 2023, panelists provided guidance for reducing disparities and improving health equity for patients who are negatively impacted by social determinants of health.

Filed under:ACR ConvergenceGuidanceLegislation & AdvocacyMeeting ReportsProfessional Topics Tagged with:ACR Convergence 2023Equity

ARP Welcomes a New President: A Conversation with Aileen Ledingham, PT, MS, PhD

Leslie Mertz, PhD  |  November 14, 2023

With roots in physical therapy & rehabilitation research, Dr. Ledingham brings to the ARP a deep enthusiasm for volunteering & collaboration, as well as a commitment to building public knowledge about the field of rheumatology.

Filed under:ACR ConvergenceInterprofessional PerspectiveProfessional Topics

Ignite the Spark of Joy & Discovery

Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS  |  September 9, 2023

A Roshi (i.e., master) apparently said that in Zen, “there is nothing to believe and everything to discover.” Interestingly enough, I have never been able to confirm who actually said that, which makes this saying about belief and discovery particularly apt. Regardless, I think about those words at least twice a day when I am…

Filed under:Career DevelopmentEducation & TrainingOpinionProfessional TopicsRheuminations

Case Report: Migratory Polyarthritis as the Presenting Symptom of GPA

Adil Vural, MD, & Kinanah Yaseen, MD  |  May 9, 2023

Granulomatosis with polyangiitis (GPA) is a primary, necrotizing granulomatous vasculitis, involving small- to medium-sized arteries, that causes systemic disease. Almost any organ can be affected, but the most affected systems are the upper airways, lungs, kidneys, eyes and peripheral nerves. Migratory polyarthritis is reported in approximately 25% of patients with anti-neutrophil cytoplasmic antibody (ANCA) associated…

Filed under:ConditionsVasculitis Tagged with:AAV FocusRheumANCA-Associated Vasculitiscase reportGranulomatosisgranulomatosis with polyangiitismigratory polyarthritis

What We Know about COVID-19 in 2023: Variants, Vaccines, New Therapies & More

Ruth Jessen Hickman, MD  |  March 16, 2023

Although a less central focus than it was three years ago, rheumatologists must still consider the prevention and management of SARS-CoV-2 in their patients. The following update shares ongoing considerations related to the COVID-19 pandemic. Outcomes At the beginning of the pandemic, it was unclear whether patients with rheumatic disease would be at higher risk…

Filed under:Conditions Tagged with:COVID-19SARS-CoV-2

  • « Previous Page
  • 1
  • …
  • 25
  • 26
  • 27
  • 28
  • 29
  • …
  • 49
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences